---
figid: PMC9485988__mpp-0031-0303-g01
pmcid: PMC9485988
image_filename: mpp-0031-0303-g01.jpg
figure_link: /pmc/articles/PMC9485988/figure/F1/
number: Fig. 1
figure_title: ''
caption: 'Simplified representation of the DNA damage response (DDR) signaling pathways:
  synthetic lethality by PARP inhibitors in HRR-deficient cancer cells, whereas repair
  of double strand breaks occurs in normal, non cancerous cells according to the HRR
  pathway (reproduced from Cortesi et al. []). HRR, homologous recombination repair;
  PARP, poly(ADP-ribose) polymerase. Reproduced according to the licensing conditions
  of http://creativecommons.org/licenses/by/4.0/.'
article_title: 'PARP Inhibition and Beyond in BRCA-Associated Breast Cancer in Women:
  A State-Of-The-Art Summary of Preclinical Research on Risk Reduction and Clinical
  Benefits.'
citation: Ernest K.J. Pauwels, et al. Med Princ Pract. 2022 Sep;31(4):303-312.
year: '2022'

doi: 10.1159/000525281
journal_title: Medical Principles and Practice
journal_nlm_ta: Med Princ Pract
publisher_name: S. Karger AG

keywords:
- Female breast cancer
- BRCA1/2 mutation
- PARP inhibitors
- Synthetic lethality
- PARP inhibitor resistance

---
